cilostazol

Generic: cilostazol

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 100 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-986
Product ID 62135-986_3dfa32ae-94ba-4885-e063-6394a90a9333
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077021
Listing Expiration 2026-12-31
Marketing Start 2004-11-23

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135986
Hyphenated Format 62135-986

Supplemental Identifiers

RxCUI
242461 242462
UPC
0362135986605 0362135983604
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077021 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (62135-986-60)
source: ndc

Packages (1)

62135-986-60 60 TABLET in 1 BOTTLE (62135-986-60)

Ingredients (1)

cilostazol (100 mg/1)

Linked Drug Pages (1)

Cilostazol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3dfa32ae-94ba-4885-e063-6394a90a9333", "openfda": {"nui": ["N0000175598", "N0000175086"], "upc": ["0362135986605", "0362135983604"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["77e77eaf-5556-43ac-844e-c0e29f02fe07"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (62135-986-60)", "package_ndc": "62135-986-60", "marketing_start_date": "20250827"}], "brand_name": "Cilostazol", "product_id": "62135-986_3dfa32ae-94ba-4885-e063-6394a90a9333", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "62135-986", "generic_name": "Cilostazol", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "100 mg/1"}], "application_number": "ANDA077021", "marketing_category": "ANDA", "marketing_start_date": "20041123", "listing_expiration_date": "20261231"}